CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2016 net revenues and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year ending September 30, 2016, management expects net revenue growth of 3% to 5% on a constant currency basis, […]
BUFFALO, NY — Rand Capital Corporation (NASDAQ: RAND) (“Rand”), a business development company that makes venture capital investments in companies with emerging product, service or technology concepts, announced that it recently invested $250,000 as part of a $4.3 million equity capital funding round in SciAps, Inc. (https://sciaps.com/). SciAps is the leading provider of handheld analytical […]
ALAMEDA, Calif. & TEL AVIV, Israel — BioTime, Inc. (NYSE MKT: BTX), a biotechnology company focused on the development and commercialization of cell-based therapies, announced today that the Tel Aviv Stock Exchange (TASE) has approved the new listing of BioTime’s common shares beginning on Tuesday, September 8, 2015 under the ticker symbol BTX. Based on […]
LANCASTER, Calif. — Simulations Plus, Inc. (NASDAQ: SLP), the leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it had been notified by the U.S. Food and Drug Administration (FDA) that the company has been awarded a second cooperative agreement for $200,000 per year for up to three years. […]
Berlin — labfolder, the digital laboratory notebook software for research closes a seven-digit growth financing round for further development of the software platform, and expanding marketing and international sales. The lead investor of the current financing round is the Charité Biomedical Fund, (CBF-1) under the management of Peppermint VenturePartners. Previous investment partners VC Fonds Technologie […]
Darmstadt, Germany – Merck, a leading company for innovative, topquality high-tech products in healthcare, life science and performance materials, successfully placed euro bonds today via its subsidiary Merck Financial Services GmbH. This serves the financing of the proposed acquisition of the U.S. life science company Sigma-Aldrich. In total, three tranches were placed: a floating rate […]
BEVERLY, Mass. — Thrive Bioscience announced today it closed a $4.0 million round of seed financing from angel groups, strategic partners and industry veterans to accelerate commercialization of previously unavailable solutions that advance drug discovery, research and delivery of new therapies by improving one of the most important research processes – cell culture. Investors in […]
DELRAY BEACH, Fla. — PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today it has entered into definitive agreements with an institutional investor (“Investor”) for an aggregate purchase price of $2,400,000. PositiveID will use the proceeds to continue the development and testing of its Firefly Dx PCR (polymerase […]
Jena, Germany — Endress+Hauser’s voluntary tender to the shareholders of Analytik Jena AG has been extended to 9 September 2015. The Group, which holds more than 95 percent of the German company, will continue to offer 14 euros a share The voluntary tender from Endress+Hauser was first initiated in July of this year. Following the […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ:ILMN) today announced Illumina Accelerator–the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry–has selected three new startups for its second funding cycle. Selected from a competitive pool of highly qualified applicants, the new startups from across the globe are spurring genomics innovation in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
